糖尿病治療藥的全球市場規模調查，各產品，各地區預測2022-2028

全球糖尿病治療藥市場在2021年估算為1兆3,898億3,000萬美元，在預測期間的2022-2028年預計將以10.40％以上健全的成長率增長。

本調查的目的是定義近年來各個細分市場和國家的市場規模，並在未來幾年預測它們的價值。本報告設計內容涵蓋調查對象國家產業的定性和定量雙方面。

此外也提供市場未來性的成長促進因素和課題等重要方面相關之詳細資訊。再加上主要企業的競爭情形和提供產品之詳細分析，並涵括利害關係者投資所需的微觀市場潛在機會。詳細的市場區隔和子區隔如下列。

各產品

注射劑

口服糖尿病治療藥

各地區

北美

美國

加拿大

歐洲

英國

德國

法國

西班牙

義大利

其他歐洲

亞洲·太平洋

中國

印度

日本

澳洲

韓國

其他亞太地區

南美

巴西

墨西哥

其他地區

本調查涵括年份如下。

實際成果年-2018年，2019年，2020年

基準年-2021

預測期間-從2022年到2028年

本報告，全球糖尿病治療藥市場主要讀者。

主要的諮詢公司·顧問

大企業，中堅企業，中小企業

創業投資

增值轉售商(VAR)

第三方知識供應商

投資銀行家

投資者

目錄

第1章 摘要整理

• 市場概述
• 全球市場·市場區隔的估計·預測，2020-2028年
  • 糖尿病治療藥的全球市場:各地區，2020-2028年
  • 糖尿病治療藥的全球市場:各產品):2020-2028年
• 主要趨勢
• 調查手法
• 調查前提條件

第2章 糖尿病治療藥的全球市場定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查目標範圍
  • 產業的演進
• 調查對象年
• 貨幣換算比率

第3章 全球糖尿病治療藥市場力學

• 糖尿病治療藥市場影響分析(2020-2028年)
  • 推動市場要素
  • 市場課題
  • 市場機會

第4章 全球糖尿病治療藥市場產業分析

• 波特的5力模式
  • 供給企業談判力
  • 買方議價能力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係
  • 波特五力分析的未來性方法(2018-2028年)
• PEST分析
  • 政治
  • 經濟
  • 社會
  • 技術性
• 投資採用模式
• 分析師的結論·建議
• 頂級投資機會
• 主要成功策略

第5章 風險評估:COVID-19衝擊

• COVID-19對產業帶來的整體影響的評估
• COVID-19以前和COVID-19以後的市場情景

第6章 糖尿病治療藥的全球市場:各產品

• 市場概述
• 糖尿病治療藥的全球市場:各產品，性能-潛在力分析
• 糖尿病治療藥的全球市場，各產品估計·預測2018～2028年
• 糖尿病治療藥市場，子區隔分析
  • 注射劑
  • 口服抗糖尿病藥物

第7章 糖尿病治療藥的全球市場:各地區分析

• 糖尿病治療藥市場，各地區市場概述
• 北美
  • 美國
    • 產品估計·預測，2018年～2028年
  • 加拿大
• 歐洲糖尿病治療藥市場概述
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他的歐洲地區
• 亞太地區的糖尿病治療藥市場概述
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美的糖尿病治療藥市場概述
  • 巴西
  • 墨西哥
• 全球其他地區

第8章 競爭資訊

• 頂級市場策略
• 企業簡介
  • Astrazenecaplc
    • 主要的資訊
    • 概要
    • 根據財務(資料的得到情形不同)
    • 產品概要
    • 最近的開發情形
  • Boehringer Ingelheim Gmbh
  • Eli Lilly And Company
  • GlaxoSmithKline plc
  • Novartis AG
  • Novo Nordisk
  • Sanofi S.A
  • Takeda Pharmaceutical Company Limited
  • Johnson And Johnson MD&D
  • Merck And Co.

第9章 調查流程

• 調查流程
  • 資料探勘
  • 分析
  • 市場估計
  • 驗證
  • 出版
• 調查屬性
• 調查前提條件

Global Diabetes Therapeutics Market is valued approximately USD 1389.83 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.40 % over the forecast period 2022-2028. Diabetes Therapeutics refers to various treatment techniques utilized for the treatment of a diabetic patient such as insulin injections, pumps, and oral drugs among others. Diabetes is a chronic metabolic disease that occurs when the pancreas is no longer able to produce insulin or the body is unable to fully utilize the insulin it produces. it is characterized by an elevated level of glucose that causes ill impacts on the heart. Increase in prevalence of diabetes due to increasing obesity among people caused by unhealthy diets and sedentary lifestyles. The increasing number of programs initiated by various healthcare organizations for raising awareness about diabetes. For Instance: according to the International Diabetes Federation (IDF), it was reported that approximately 537 million adults (20-79 years) are living with diabetes, and the number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. In addition, the Centers for Disease Control and Prevention (CDC) in the U.S. announced the launch of the National Diabetes Prevention Program (National DPP), along with the partnership of public and private organizations. The National Diabetes Prevention Program aims to prevent or delay type 2 diabetes. Also, the increase in research and development in the healthcare sector, the introduction of advanced drug in the market and new product approvals in the market contribute to the growth of the diabetes market. Rise in the geriatric and obese population. according to the Center for Aging Better, in 2021, there are almost 12 million people aged 65 and over in the UK, with 3.2 million aged 80 and over thus increase in several geriatric populations is likely to increase the market growth during the forecast period. However, Various side effects associated with the long-term use of anti-diabetes drug impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Diabetes Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America and the Rest of the World. North America dominated the global insulin therapeutics market in 2021, owing to the high prevalence of diabetes in the region because of the sedentary lifestyle and the launch of new drugs in the region. The United States is expected to grow tremendously during the forecast period, owing to factors, such as the high prevalence of obesity and increasing awareness regarding diabetes care in the region.

Major market players included in this report are:

Astrazeneca plc

Boehringer Ingelheim Gmbh

Eli Lilly And Company

GlaxoSmithKline plc

Novartis AG

Novo Nordisk

Sanofi S.A

Takeda Pharmaceutical Company Limited

Johnson And Johnson MD&D

Merck And Co.

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Injectables

Oral antidiabetic Drugs

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period: - 2022 to 2028

Target Audience of the Global Diabetes Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Global Diabetes Therapeutics Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Global Diabetes Therapeutics Market, by Product, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Diabetes Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Diabetes Therapeutics Market Dynamics

• 3.1. Diabetes Therapeutics Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of diabetes
    • 3.1.1.2. Favourable initiatives from government authorities.
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects associated with long-term use of anti-diabetes drug.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing number of R&D activities in healthcare sector
    • 3.1.3.2. Increasing number of geriatric and obese individuals.

Chapter 4. Global Diabetes Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Diabetes Therapeutics Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Diabetes Therapeutics Market by Product, Performance - Potential Analysis
• 6.3. Global Diabetes Therapeutics Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
• 6.4. Diabetes Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Injectables
  • 6.4.2. Oral antidiabetic Drugs

Chapter 7. Global Diabetes Therapeutics Market, Regional Analysis

• 7.1. Diabetes Therapeutics Market, Regional Market Snapshot
• 7.2. North America Diabetes Therapeutics Market
  • 7.2.1. U.S. Diabetes Therapeutics Market
    • 7.2.1.1. Product estimates & forecasts, 2018-2028
  • 7.2.2. Canada Diabetes Therapeutics Market
• 7.3. Europe Diabetes Therapeutics Market Snapshot
  • 7.3.1. U.K. Diabetes Therapeutics Market
  • 7.3.2. Germany Diabetes Therapeutics Market
  • 7.3.3. France Diabetes Therapeutics Market
  • 7.3.4. Spain Diabetes Therapeutics Market
  • 7.3.5. Italy Diabetes Therapeutics Market
  • 7.3.6. Rest of Europe Diabetes Therapeutics Market
• 7.4. Asia-Pacific Diabetes Therapeutics Market Snapshot
  • 7.4.1. China Diabetes Therapeutics Market
  • 7.4.2. India Diabetes Therapeutics Market
  • 7.4.3. Japan Diabetes Therapeutics Market
  • 7.4.4. Australia Diabetes Therapeutics Market
  • 7.4.5. South Korea Diabetes Therapeutics Market
  • 7.4.6. Rest of Asia Pacific Diabetes Therapeutics Market
• 7.5. Latin America Diabetes Therapeutics Market Snapshot
  • 7.5.1. Brazil Diabetes Therapeutics Market
  • 7.5.2. Mexico Diabetes Therapeutics Market
• 7.6. Rest of The World Diabetes Therapeutics Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Astrazenecaplc
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Boehringer Ingelheim Gmbh
  • 8.2.3. Eli Lilly And Company
  • 8.2.4. GlaxoSmithKline plc
  • 8.2.5. Novartis AG
  • 8.2.6. Novo Nordisk
  • 8.2.7. Sanofi S.A
  • 8.2.8. Takeda Pharmaceutical Company Limited
  • 8.2.9. Johnson And Johnson MD&D
  • 8.2.10. Merck And Co.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Diabetes Therapeutics Market, report scope
• TABLE 2. Global Diabetes Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Diabetes Therapeutics Market estimates & forecasts by Product 2018-2028 (USD Billion)
• TABLE 4. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 5. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 6. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 7. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Diabetes Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Diabetes Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. U.S. Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 16. U.S. Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 17. Canada Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 18. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 19. Canada Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 20. UK Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 21. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 22. UK Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 23. Germany Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 24. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 25. Germany Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 26. RoE Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 27. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 28. RoE Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 29. China Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 30. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 31. China Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 32. India Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 33. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 34. India Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 35. Japan Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 36. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 37. Japan Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 38. RoAPAC Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 39. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 40. RoAPAC Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 41. Brazil Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 42. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 43. Brazil Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 44. Mexico Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 45. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 46. Mexico Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 47. RoLA Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 48. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 49. RoLA Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 50. Row Diabetes Therapeutics Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 51. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 52. Row Diabetes Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 53. List of secondary sources, used in the study of global Diabetes Therapeutics Market
• TABLE 54. List of primary sources, used in the study of global Diabetes Therapeutics Market
• TABLE 55. Years considered for the study
• TABLE 56. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Diabetes Therapeutics Market, research methodology
• FIG 2. Global Diabetes Therapeutics Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Diabetes Therapeutics Market, key trends 2021
• FIG 5. Global Diabetes Therapeutics Market, growth prospects 2022-2028
• FIG 6. Global Diabetes Therapeutics Market, porters 5 force model
• FIG 7. Global Diabetes Therapeutics Market, pest analysis
• FIG 8. Global Diabetes Therapeutics Market, value chain analysis
• FIG 9. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Diabetes Therapeutics Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Diabetes Therapeutics Market, regional snapshot 2018 & 2028
• FIG 15. North America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 17. Asia pacific market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Diabetes Therapeutics Market 2018 & 2028 (USD Billion)
• FIG 19. Global Diabetes Therapeutics Market, company market share analysis (2021)